The consumer's role in development of orphan drugs
Meyers, A.S.
Progress in Clinical and Biological Research 197: 51-61
1985
ISSN/ISBN: 0361-7742 PMID: 3865230 Document Number: 253333
Document emailed within 1 workday
Related Documents
Campos-Castelló, J. 2001: Orphan drugs and orphan diseases Revista de Neurologia 33(3): 216-220Thielke, D.ée.; Thyssen, J.P.; Hansen, B.J. 2006: Orphan drugs--medications for patients with rare diseases Ugeskrift for Laeger 168(23): 2236-2238
Kuzelová, M.; Kubácková, K.; Palágyi, M.; Smíd, M. 2006: Hope for patients with rare diseases--"orphan" drugs Casopis Lekaru Ceskych 145(4): 296-300
Juma, M.; Alaii, J.; Bartholomew, L.K.; Askew, I.; Van den Borne, B. 2013: Risky sexual behavior among orphan and non-orphan adolescents in Nyanza Province, Western Kenya Aids and Behavior 17(3): 951-960
Meldrum, D.R.; Chang, R.J.; de Ziegler, D.; Schoolcraft, W.B.; Scott, R.T.; Pellicer, A. 2009: Adjuncts for ovarian stimulation: when do we adopt "orphan indications" for approved drugs? Fertility and Sterility 92(1): 13-18
Bai, R.; Liu, N.; Hu, D.; Ma, C. 2014: Urgent action is needed to change the status of "orphan drugs" in cardiology in China Zhonghua Xin Xue Guan Bing Za Zhi 42(7): 543-544
Manuel, J.; Collin-Histed, T. 2013: Orphan drug development and the impact on non-medical support groups Pediatric Endocrinology Reviews: Per 11(Suppl 1): 116-124
Whyte, J. 1993: Direct consumer advertising of prescription drugs JAMA 269(1): 146 150
Szupera, Z.án. 2007: The role of the antiepileptic drugs at the development of the sexual dysfunctions in male epileptic patients Ideggyogyaszati Szemle 60(1-2): 4-13
Peters, P.W.; Verburg, H. 1987: The importance of health protection of the consumer in relation to veterinary drugs Tijdschrift Voor Diergeneeskunde 112(8): 486-490
Campbell, P.; Handa, S.; Moroni, M.; Odongo, S.; Palermo, T. 2010: Assessing the "orphan effect" in determining development outcomes for children in 11 eastern and southern African countries Vulnerable Children and Youth Studies 5(1): 12-32
Fukuda, A.; Ishida, H.; Kubota, M.; Kojima, Y. 2005: Development of analysis of drugs and toxic substances that can play an immediate role in emergency medical service: what is to be analyzed? Rinsho Byori. Japanese Journal of Clinical Pathology 53(1): 26-33
McCormack, L.A.; Garfinkel, S.A.; Schnaier, J.A.; Lee, A.J.; Sangl, J.A. 1996: Consumer information development and use Health Care Financing Review 18(1): 15-30
Navarro, R.P. 1998: The role of direct-to-consumer advertising Managed Care Interface 11(11): 79-80 82
Kelly, E.L.; Davis, L.; Mendon, S.; Kiger, H.; Murch, L.; Pancake, L.; Giambone, L.; Brekke, J.S. 2019: Provider and consumer perspectives of community mental health services: Implications for consumer-driven care Psychological Services 16(4): 572-584
Mosconi, P.; Groth, N.; Apolone, G.; Niero, M.; Oprandi, N.; Belloli, A.; Mannino, S. 2003: Development and validation of a questionnaire measuring hospital consumer satisfaction Annali di Igiene: Medicina Preventiva e di Comunita 15(4): 341-362
Mishra, M.; Kushwaha, R.; Gupta, N.; Sinha, A.; Dwivedi, H. 2023: Survey data to evaluate consumer behaviour and consumption pattern of sustainable apparel: a study on consumer awareness level Data in Brief 49: 109350
Ungváry, G. 1985: The possible contribution of industrial chemicals (organic solvents) to the incidence of congenital defects caused by teratogenic drugs and consumer goods--an experimental study Progress in Clinical and Biological Research 163b: 295-300
Gemperli, M.P. 2000: MSJAMA: rethinking the role of the learned intermediary: the effect of direct-to-consumer advertising on litigation JAMA 284(17): 2241
Gustafson, D.H.; Hawkins, R.P.; Boberg, E.W.; McTavish, F.; Owens, B.; Wise, M.; Berhe, H.; Pingree, S. 2001: CHESS: ten years of research and development in consumer health informatics for broad populations, including the underserved Studies in Health Technology and Informatics 84(Pt 2): 1459-1563